212 related articles for article (PubMed ID: 35318338)
1. Angiopathic activity of LRG1 is induced by the IL-6/STAT3 pathway.
Dritsoula A; Dowsett L; Pilotti C; O'Connor MN; Moss SE; Greenwood J
Sci Rep; 2022 Mar; 12(1):4867. PubMed ID: 35318338
[TBL] [Abstract][Full Text] [Related]
2. LRG1 mediated by ATF3 promotes growth and angiogenesis of gastric cancer by regulating the SRC/STAT3/VEGFA pathway.
He L; Feng A; Guo H; Huang H; Deng Q; Zhao E; Yang M
Gastric Cancer; 2022 May; 25(3):527-541. PubMed ID: 35094168
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer-associated fibroblasts promote metastasis by up-regulating LRG1 through stromal IL-6/STAT3 signaling.
Zhong B; Cheng B; Huang X; Xiao Q; Niu Z; Chen YF; Yu Q; Wang W; Wu XJ
Cell Death Dis; 2021 Dec; 13(1):16. PubMed ID: 34930899
[TBL] [Abstract][Full Text] [Related]
4. LRG1 facilitates corneal fibrotic response by inducing neutrophil chemotaxis via Stat3 signaling in alkali-burned mouse corneas.
Yu B; Yang L; Song S; Li W; Wang H; Cheng J
Am J Physiol Cell Physiol; 2021 Sep; 321(3):C415-C428. PubMed ID: 34260299
[TBL] [Abstract][Full Text] [Related]
5. LRG1 destabilizes tumor vessels and restricts immunotherapeutic potency.
O'Connor MN; Kallenberg DM; Camilli C; Pilotti C; Dritsoula A; Jackstadt R; Bowers CE; Watson HA; Alatsatianos M; Ohme J; Dowsett L; George J; Blackburn JWD; Wang X; Singhal M; Augustin HG; Ager A; Sansom OJ; Moss SE; Greenwood J
Med; 2021 Nov; 2(11):1231-1252.e10. PubMed ID: 35590198
[TBL] [Abstract][Full Text] [Related]
6. Early Enhanced Leucine-Rich
Haku S; Wakui H; Azushima K; Haruhara K; Kinguchi S; Ohki K; Uneda K; Kobayashi R; Matsuda M; Yamaji T; Yamada T; Minegishi S; Ishigami T; Yamashita A; Ohashi K; Tamura K
Biomed Res Int; 2018; 2018():2817045. PubMed ID: 30515388
[TBL] [Abstract][Full Text] [Related]
7. TNF-α-induced LRG1 promotes angiogenesis and mesenchymal stem cell migration in the subchondral bone during osteoarthritis.
Wang Y; Xu J; Zhang X; Wang C; Huang Y; Dai K; Zhang X
Cell Death Dis; 2017 Mar; 8(3):e2715. PubMed ID: 28358372
[TBL] [Abstract][Full Text] [Related]
8. Structural basis of human LRG1 recognition by Magacizumab, a humanized monoclonal antibody with therapeutic potential.
Gutiérrez-Fernández J; Javaid F; De Rossi G; Chudasama V; Greenwood J; Moss SE; Luecke H
Acta Crystallogr D Struct Biol; 2022 Jun; 78(Pt 6):725-734. PubMed ID: 35647920
[TBL] [Abstract][Full Text] [Related]
9. LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-
Hong Q; Zhang L; Fu J; Verghese DA; Chauhan K; Nadkarni GN; Li Z; Ju W; Kretzler M; Cai GY; Chen XM; D'Agati VD; Coca SG; Schlondorff D; He JC; Lee K
J Am Soc Nephrol; 2019 Apr; 30(4):546-562. PubMed ID: 30858225
[TBL] [Abstract][Full Text] [Related]
10. Leucine-rich α-2-glycoprotein-1 promotes diabetic corneal epithelial wound healing and nerve regeneration via regulation of matrix metalloproteinases.
Li W; Wang X; Cheng J; Li J; Wang Q; Zhou Q; Li H; Xue J; Zhang Y; Yang L; Xie L
Exp Eye Res; 2020 Jul; 196():108060. PubMed ID: 32387619
[TBL] [Abstract][Full Text] [Related]
11. LRG1: an emerging player in disease pathogenesis.
Camilli C; Hoeh AE; De Rossi G; Moss SE; Greenwood J
J Biomed Sci; 2022 Jan; 29(1):6. PubMed ID: 35062948
[TBL] [Abstract][Full Text] [Related]
12. The Leucine-Rich α2-Glycoprotein-1 Levels in Patients with Multiple Myeloma.
Kaçmaz M; Oğuzman H
Oncol Res Treat; 2023; 46(10):415-423. PubMed ID: 37527638
[TBL] [Abstract][Full Text] [Related]
13. LRG1 in pancreatic cancer cells promotes inflammatory factor synthesis and the angiogenesis of HUVECs by activating VEGFR signaling.
Cai D; Chen C; Su Y; Tan Y; Lin X; Xing R
J Gastrointest Oncol; 2022 Feb; 13(1):400-412. PubMed ID: 35284128
[TBL] [Abstract][Full Text] [Related]
14. Latrophilin-2 is a novel receptor of LRG1 that rescues vascular and neurological abnormalities and restores diabetic erectile function.
Yin GN; Kim DK; Kang JI; Im Y; Lee DS; Han AR; Ock J; Choi MJ; Kwon MH; Limanjaya A; Jung SB; Yang J; Min KW; Yun J; Koh Y; Park JE; Hwang D; Suh JK; Ryu JK; Kim HM
Exp Mol Med; 2022 May; 54(5):626-638. PubMed ID: 35562586
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of long noncoding RNA-taurine-upregulated gene 1 inhibits tumor angiogenesis in ovarian cancer by regulating leucine-rich α-2-glycoprotein-1.
Fan M; Li C; He P; Fu Y; Li M; Zhao X
Anticancer Drugs; 2019 Jul; 30(6):562-570. PubMed ID: 30896502
[TBL] [Abstract][Full Text] [Related]
16. LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling.
Wang X; Abraham S; McKenzie JAG; Jeffs N; Swire M; Tripathi VB; Luhmann UFO; Lange CAK; Zhai Z; Arthur HM; Bainbridge J; Moss SE; Greenwood J
Nature; 2013 Jul; 499(7458):306-11. PubMed ID: 23868260
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer.
Dalwadi H; Krysan K; Heuze-Vourc'h N; Dohadwala M; Elashoff D; Sharma S; Cacalano N; Lichtenstein A; Dubinett S
Clin Cancer Res; 2005 Nov; 11(21):7674-82. PubMed ID: 16278387
[TBL] [Abstract][Full Text] [Related]
18. Bazedoxifene exhibits growth suppressive activity by targeting interleukin-6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma.
Ma H; Yan D; Wang Y; Shi W; Liu T; Zhao C; Huo S; Duan J; Tao J; Zhai M; Luo P; Guo J; Tian L; Mageta L; Jou D; Zhang C; Li C; Lin J; Lv J; Li S; Lin L
Cancer Sci; 2019 Mar; 110(3):950-961. PubMed ID: 30648776
[TBL] [Abstract][Full Text] [Related]
19. LRG1 promotes angiogenesis through upregulating the TGF‑β1 pathway in ischemic rat brain.
Meng H; Song Y; Zhu J; Liu Q; Lu P; Ye N; Zhang Z; Pang Y; Qi J; Wu H
Mol Med Rep; 2016 Dec; 14(6):5535-5543. PubMed ID: 27840991
[TBL] [Abstract][Full Text] [Related]
20. LRG1 Promotes Metastatic Dissemination of Melanoma through Regulating EGFR/STAT3 Signalling.
Kwan YP; Teo MHY; Lim JCW; Tan MS; Rosellinny G; Wahli W; Wang X
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34208965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
